These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 1730192
1. [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia]. Giers G, Salama A, Mueller-Eckhardt C. Dtsch Med Wochenschr; 1992 Jan 03; 117(1):1-5. PubMed ID: 1730192 [Abstract] [Full Text] [Related]
2. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura]. Vizcaíno G, Diez-Ewald M, Arteaga-Vizcaíno M, Torres E. Invest Clin; 1992 Jan 03; 33(4):165-74. PubMed ID: 1338940 [Abstract] [Full Text] [Related]
3. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura. Estrada-Gómez R, Vargas-Castro O, Oropeza-Borges M, González-Carrillo ML, Pérez-Romano B, Ruiz-Argüelles GJ. Rev Invest Clin; 2007 Jan 03; 59(6):424-7. PubMed ID: 18402333 [Abstract] [Full Text] [Related]
4. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study. Monteleone PM, Vander Heyden MA, Steele DA, Kelleher JF. Haematologica; 2000 Aug 03; 85(8):887-8. PubMed ID: 10942950 [No Abstract] [Full Text] [Related]
5. [Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia]. Pfeilstöcker M, Waldner R, Reisner R, Heinz R, Pittermann E. Infusionsther Transfusionsmed; 1995 Aug 03; 22(4):220-4. PubMed ID: 7496120 [Abstract] [Full Text] [Related]
7. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. Fehr J, Hofmann V, Kappeler U. N Engl J Med; 1982 May 27; 306(21):1254-8. PubMed ID: 6803159 [Abstract] [Full Text] [Related]
8. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin. Smith NA, Chakraverty RK, Boughton BJ. Clin Lab Haematol; 1990 May 27; 12(2):131-6. PubMed ID: 2119931 [Abstract] [Full Text] [Related]
9. Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Meyer O, Kiesewetter H, Hermsen M, Petriedes P, Rose M, Seibt H, Salama A. Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):721-2. PubMed ID: 16933269 [Abstract] [Full Text] [Related]
11. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment. Leitner GC, Stiegler G, Horvath M, Hoecker P, Sagaster P, Panzer S. Am J Hematol; 2003 May 15; 73(1):44-7. PubMed ID: 12701120 [Abstract] [Full Text] [Related]
12. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Haematologica; 2005 Jun 15; 90(6):829-32. PubMed ID: 15951296 [Abstract] [Full Text] [Related]
13. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, DeVeber LB, Esseltine D, Israels S, Korbrinsky N. J Pediatr; 1992 Apr 15; 120(4 Pt 1):522-7. PubMed ID: 1313096 [Abstract] [Full Text] [Related]
14. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C, Reu FJ, Ho AD, Hensel M. Ann Hematol; 2007 Oct 15; 86(10):711-7. PubMed ID: 17622529 [Abstract] [Full Text] [Related]
15. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP). Rewald MD, Francischetti MM. Transfus Apher Sci; 2004 Apr 15; 30(2):105-10. PubMed ID: 15062747 [Abstract] [Full Text] [Related]
16. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children. Kjaersgaard M, Edslev PW, Hasle H. Pediatr Blood Cancer; 2009 Dec 15; 53(7):1315-7. PubMed ID: 19722275 [Abstract] [Full Text] [Related]
17. Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura. Yaprak I, Cağlayan S, Kansoy S, Ozdoğru E, Bakiler AR, Aydinlioğlu H. Turk J Pediatr; 1994 Dec 15; 36(1):43-7. PubMed ID: 8191607 [Abstract] [Full Text] [Related]
18. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison. Scaradavou A, Cunningham-Rundles S, Ho JL, Folman C, Doo H, Bussel JB. Am J Hematol; 2007 May 15; 82(5):335-41. PubMed ID: 17154377 [Abstract] [Full Text] [Related]
19. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins. Mehta YS, Badakere SS. J Postgrad Med; 1996 May 15; 42(2):46-9. PubMed ID: 9715299 [Abstract] [Full Text] [Related]
20. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases. Schiavotto C, Rodeghiero F. Haematologica; 1993 May 15; 78(6 Suppl 2):22-8. PubMed ID: 8039754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]